Table 4.
Included studies | Sample size | Age | Treatment group interventions | Control group interventions |
Course of treatment | Outcome |
---|---|---|---|---|---|---|
(41) | T: 36 C: 36 |
T:/ C:/ |
Acupuncture + HCG | HCG | 4 weeks | Pregnancy rate |
(40) | T: 30 C: 30 |
T: 32.51 ± 2.75 C: 31.79 ± 3.62 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(38) | T: 36 C: 36 |
T: 23–38 C: 22–38 |
Acupuncture + HCG | HCG | 3 menstrual cycles | Pregnancy rate |
(39) | T: 43 C: 41 |
T:/ C:/ |
Acupuncture + HCG + letrozole | HCG + letrozole | 3 menstrual cycles | Pregnancy rate |
(35) | T: 30 C: 30 |
T: 29.30 ± 3.67 C: 28.37 ± 3.79 |
Acupuncture | HCG | No report | Pregnancy rate |
(37) | T: 33 C: 33 |
T: 23–40 C: 23–40 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(36) | T: 40 C: 40 |
T: 25.8 ± 2.56 C: 24.8 ± 2.16 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(34) | T: 30 C: 30 |
T: 28.27 ± 3.84 C: 28.85 ± 2.13 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(33) | T: 32 C: 32 |
T: 29.59 ± 3.44 C: 31.22 ± 12.79 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(32) | T: 30 C: 30 |
T: 31.87 ± 3.58 C: 31.77 ± 3.63 |
Acupuncture + HCG | HCG | 1 month | Pregnancy rate |
(31) | T: 30 C: 30 |
T:/ C:/ |
Acupuncture | HCG | No report | Pregnancy rate |
(29) | T: 33 C: 32 |
T: 29.39 ± 4.39 C: 29.22 ± 4.15 |
Acupuncture | HCG | 3 months | Pregnancy rate |
(30) | T: 30 C: 26 |
T: 30.27 ± 3.44 C: 30.07 ± 2.89 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(28) | T: 25 C: 25 |
T: 30.48 ± 4.03 C: 29.71 ± 3.05 |
Acupuncture | HCG | 3 menstrual cycles | Pregnancy rate |
(27) | T: 25 C: 25 |
T: 30.88 ± 3.37 C: 31.60 ± 4.56 |
Acupuncture | No treatment | No report | Pregnancy rate |
(26) | T: 40 C: 40 |
T: 29.18 ± 2.63 C: 29.00 ± 2.71 |
Acupuncture + HCG + endovascular therapy | HCG | 3 menstrual cycles | Pregnancy rate |
(25) | T: 30 C: 30 |
T:/ C:/ |
Acupuncture + HCG | HCG | 3 menstrual cycles | Pregnancy rate |
T, treatment group; C, the control group; HCG, human chorionic gonadotropin.